Immunological Molecular Responses of Human Retinal Pigment Epithelial Cells to Infection With Toxoplasma gondii

Immunological Molecular Responses of Human Retinal Pigment Epithelial Cells to Infection With Toxoplasma gondii Shervi Lie1†, Elise Rochet1†, Erik Segerdell2, Yuefang Ma1, Liam M. Ashander1, Audra M. A. Shadforth3,4, Timothy A. Blenkinsop5, Michael Z. Michael6, Binoy Appukuttan1,6, Beth Wilmot2 and Justine R. Smith1,6* 1Eye and Vision Health, Flinders University College of Medicine and Public Health, Adelaide, SA, Australia 2Department of Biostatistics, Oregon Health and Sciences University, Portland, OR, United States 3Queensland Eye Institute, Brisbane, QLD, Australia 4School of Biomedical Science, Queensland University of Technology, Brisbane, QLD, Australia 5Departments of Cell, Developmental and Regenerative Biology, and Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, United States 6Flinders Centre for Innovation in Cancer, Flinders University College of Medicine and Public Health, Adelaide, SA, Australia Ocular toxoplasmosis is the commonest clinical manifestation of infection with obligate intracellular parasite, Toxoplasma gondii. Active ocular toxoplasmosis is characterized by replication of T. gondii tachyzoites in the retina, with reactive inflammation. The multifunctional retinal pigment epithelium is a key target cell population for T. gondii. Since the global gene expression profile is germane to understanding molecular involvements of retinal pigment epithelial cells in ocular toxoplasmosis, we performed RNA-Seq...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research

Related Links:

Publication date: Available online 10 November 2019Source: Science &SportsAuthor(s): X. BigardRésuméObjectifsLa nutrition joue un rôle indéniable pour l’excellence des performances dans les sports d’endurance. Les réserves en glucose de l’organisme sous forme de glycogène étant limitées, toute épargne du glycogène et tout substrat alternatif au glucose peuvent être utiles pour les performances. C’est ainsi que ces dernières années, les stratégies nutritionnelles destinées à augmenter la ...
Source: Science and Sports - Category: Sports Medicine Source Type: research
Authors: German C, Yeboah J PMID: 31703538 [PubMed - as supplied by publisher]
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research
I Built My Identity Around Being Bipolar. Then My Doctor Said I’m Not Bipolar What happens when what’s wrong with you isn’t what’s wrong with you? www.phillymag.com Thoughts?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Psychiatry Source Type: forums
ConclusionPET/CT-guided molecular biopsy using Ga-68 labelled radiotracers is feasible and can be performed safely and accurately with a high-diagnostic yield. It is helpful in accurately staging the disease when tracer-avid isolated distant lesion evident on imaging and highly practical in patients with previous inconclusive sampling.
Source: Diagnostic and Interventional Imaging - Category: Radiology Source Type: research
ConclusionsMRI may offer more superior diagnostic performance than CT for detecting T3-4 disease and EMVI, thereby supporting its alternative application to CT in local staging of colon cancer.
Source: European Journal of Radiology - Category: Radiology Source Type: research
tro V Abstract Immunotherapy has been showed as a promisor treatment, in special for hematological diseases. Chimeric antigen receptor T cells (CARs) which are showing satisfactory results in early-phase cancer clinical trials can be highlighted. However, preclinical models are critical steps prior to clinical trial. In this way, a well-established preclinical model is an important key in order to confirm the proof of principle. For this purpose, in this chapter will be pointed the methods to generate tumor cells expressing firefly Luciferase. In turn, these modified cells will be used to create a subcutaneous and...
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
;o-Castro V Abstract Immunotherapy using T cells modified with chimeric antigen receptor (CAR) has been proven effective in the treatment of leukemia and lymphomas resistant to chemotherapy. Recent clinical studies have shown excellent responses of CAR-T cells in a variety of B cell tumors. However, it is important to validate in vitro activity of these cells, though different sorts of assays, which are capable of measuring the cytotoxic potential of these cells. In this chapter, it will be pointed two methods to evaluate CAR-T cell killing potential against B cell malignancy cell lines. PMID: 31707679 [PubMed - in process]
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
Abstract Chimeric antigen receptor (CAR) T cell therapies are ex vivo manufactured cellular products that have been useful in the treatment of blood cancers and solid tumors. The quality of the final cellular product is influenced by several amenable factors during the manufacturing process. This review discusses several of the influences on cell product phenotype, including the raw starting material, methods of activation and transduction, and culture supplementation. PMID: 31707678 [PubMed - in process]
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
m KCR Abstract CAR-T cell immunotherapy is a promising therapeutic modality for cancer patients. The success of CAR-T cell therapy has been associated with the phenotype, activation and functional profiling of infused CAR-T cells. Therefore, immunophenotypic characterization of CAR-T cells during bioprocess is crucial for cell quality control and ultimately for improved antitumor efficacy. In this chapter, we propose a flow cytometry panel to characterize the immunophenotype of the CAR-T subsets. PMID: 31707677 [PubMed - in process]
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
Abstract Lentiviral vectors are being used in a growing number of clinical applications, including T cell immunotherapy for cancer. As this new technology moves forward, a safety concern is the inadvertent recombination and subsequent development of a replication-competent lentivirus (RCL) during the manufacture of the vector material. To assess this risk, regulators have required screening of T cell products infused into patients for RCL. Since vector particles have many of the proteins and nucleotide sequences found in RCL, a biologic assay has proven the most sensitive method for RCL detection. As regulators ha...
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
More News: Addiction | Adenocarcinoma | Allergy & Immunology | Australia Health | Biology | Biomedical Science | Bipolar | Brain | Brain Cancers | Brazil Health | Cancer | Cancer & Oncology | Cancer in Adolescents | Chemotherapy | Child Development | Children | Corticosteroid Therapy | Databases & Libraries | Dermatology | Epidemiology | Epithelial Cancer | Eyes | France Health | Funding | Genetics | Germany Health | Grants | Hydrocortisone | Infectious Diseases | Insulin | International Medicine & Public Health | Internet | Lymphoma | Mania | Medical Ethics | Men | Merck | Microbiology | Molecular Biology | Nanotechnology | Neurology | Neuroscience | Opthalmology | Parasitic Diseases | Parasitology | Pathology | Penicillin | Perinatology & Neonatology | PET Scan | Primary CNS Lymphoma | Psychiatry | Research | Schizophrenia | Science | Selenium | Sodium | Sodium Chloride | Statistics | Students | Study | Tuberculosis | Universities & Medical Training | USA Health | Vitamin A | Washington University